Prognostic significance of ambulatory ECG monitoring for ventricular arrhythmias

Progress in Cardiovascular Diseases

Volumn 56, Issue 2, 2013, Pages 133-142

  Katritsis, Demosthenes G ^a   Siontis, George C M ^b   Camm, A John ^c  

^a Athens Euroclinic ^*  (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Ambulatory ECG monitoring; Holter monitoring; Nonsustained ventricular tachycardia; Risk stratification; Ventricular arrhythmia

Indexed keywords

AMBULATORY MONITORING; ARTICLE; CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE; CARDIOVASCULAR MONITORING DEVICE; ELECTROCARDIOGRAPHY MONITORING; EXTERNAL EVENT RECORDER; EXTERNAL LOOP RECORDER; HEART DISEASE; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; MOBILE OR REAL TIME CARDIAC TELEMETRY SYSTEM; PROBABILITY; PROGNOSIS; RISK ASSESSMENT;

ACS; ACUTE CORONARY SYNDROME; AMBULATORY ECG MONITORING; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; ARVD; BRS; BRUGADA SYNDROME; CAD; CARDIAC MAGNETIC RESONANCE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICES; CATECHOLAMINERGIC POLYMORPHIC VT; CHD; CIEDS; CMR; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; CPVT; CVD; DCM; DILATED CARDIOMYOPATHY; ECG; ELECTROCARDIOGRAPHIC; ELECTROPHYSIOLOGY; ELR; EP; EXTERNAL LOOP REORDER; HEART FAILURE; HF; HOCM; HOLTER MONITORING; HYPERTROPHIC CARDIOMYOPATHY; ICD; ILR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTABLE LOOP RECORDER; LEFT VENTRICULAR; LEFT VENTRICULAR EJECTION FRACTION; LONG QT SYNDROME; LQTS; LV; LVEF; MCOT; MI; MOBILE OR REAL-TIME CARDIAC TELEMETRY; MYOCARDIAL INFARCTION; NEW YORK HEART ASSOCIATION; NON-ST-ELEVATION ACUTE CORONARY SYNDROME; NONSUSTAINED VENTRICULAR TACHYCARDIA; NSTE-ACS; NSVT; NYHA; PREMATURE VENTRICULAR COMPLEX; PVC; RIGHT VENTRICULAR; RIGHT VENTRICULAR OUTFLOW TRACT; RISK STRATIFICATION; RV; RVOT; SCD; SHORT QT SYNDROME; SQTS; ST-ELEVATION MYOCARDIAL INFARCTION; STEMI; SUDDEN CARDIAC DEATH; T-WAVE ALTERNANS; TWA; VENTRICULAR ARRHYTHMIA; VENTRICULAR FIBRILLATION; VENTRICULAR TACHYCARDIA; VF; VT;

ACUTE CORONARY SYNDROME; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, HYPERTROPHIC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROGNOSIS; RISK ASSESSMENT;

EID: 84887410423     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2013.07.005     Document Type: Article

References (85)

1. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006, 114:e385-e484.
2. Paruchuri V., Adhaduk M., Garikipati N.V., Steinberg J.S., Mittal S. Clinical utility of a novel wireless implantable loop recorder in the evaluation of patients with unexplained syncope. Heart Rhythm 2011, 8:858-863.
3. Piccini J.P., White J.A., Mehta R.H., et al. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation 2012, 126:41-49.
4. Scirica B.M., Braunwald E., Belardinelli L., et al. Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 2010, 122:455-462.
5. Katritsis D.G., Zareba W., Camm A.J. Nonsustained ventricular tachycardia. J Am Coll Cardiol 2012, 60:1993-2004.
6. Zimetbaum P., Goldman A. Ambulatory arrhythmia monitoring: choosing the right device. Circulation 2010, 122:1629-1636.
7. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009, 30:2631-2671. Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS).
8. Mittal S., Movsowitz C., Steinberg J.S. Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation. J Am Coll Cardiol 2011, 58:1741-1749.
9. Reiffel J.A., Schwarzberg R., Murry M. Comparison of autotriggered memory loop recorders versus standard loop recorders versus 24-hour Holter monitors for arrhythmia detection. Am J Cardiol 2005, 95:1055-1059.
10. Cheriyath P., He F., Peters I., et al. Relation of atrial and/or ventricular premature complexes on a two-minute rhythm strip to the risk of sudden cardiac death (the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2011, 107:151-155.
11. Tandri H., Saranathan M., Rodriguez E.R., et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005, 45:98-103.
12. Gaita F., Giustetto C., Di Donna P., et al. Long-term follow-up of right ventricular monomorphic extrasystoles. J Am Coll Cardiol 2001, 38:364-370.
13. Corrado D., Calkins H., Link M.S., et al. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 2010, 122:1144-1152.
14. Frolkis J.P., Pothier C.E., Blackstone E.H., Lauer M.S. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med 2003, 348:781-790.
15. Jouven X., Zureik M., Desnos M., Courbon D., Ducimetiere P. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med 2000, 343:826-833.
16. Cerrone M., Cummings S., Alansari T., Priori S.G. A clinical approach to inherited arrhythmias. Circ Cardiovasc Genet 2012, 5:581-590.
17. Mauriello D.A., Johnson J.N., Ackerman M.J. Holter monitoring in the evaluation of congenital long QT syndrome. Pacing Clin Electrophysiol 2011, 34:1100-1104.
18. Biffi A., Maron B.J., Culasso F., et al. Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities. Am J Cardiol 2011, 107:697-703.
19. Hofsten D.E., Wachtell K., Lund B., Molgaard H., Egstrup K. Prevalence and prognostic implications of non-sustained ventricular tachycardia in ST-segment elevation myocardial infarction after revascularization with either fibrinolysis or primary angioplasty. Eur Heart J 2007, 28:407-414.
20. Lorenz H., Junger C., Seidl K., et al. Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction?. Eur Heart J 2005, 26:1078-1085.
21. Volpi A., Cavalli A., Turato R., Barlera S., Santoro E., Negri E. Incidence and short-term prognosis of late sustained ventricular tachycardia after myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-3) Data Base. Am Heart J 2001, 142:87-92.
22. Pires L.A., Lehmann M.H., Buxton A.E., Hafley G.E., Lee K.L. Multicenter Unsustained Tachycardia Trial I Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications. J Am Coll Cardiol 2001, 38:1156-1162.
23. Cheema A.N., Sheu K., Parker M., Kadish A.H., Goldberger J.J. Nonsustained ventricular tachycardia in the setting of acute myocardial infarction: tachycardia characteristics and their prognostic implications. Circulation 1998, 98:2030-2036.
24. Hohnloser S.H., Klingenheben T., Zabel M., Schopperl M., Mauss O. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1999, 33:1895-1902.
25. Bloch Thomsen P.E., Jons C., Raatikainen M.J., et al. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study. Circulation 2010, 122:1258-1264.
26. La Rovere M.T., Pinna G.D., Hohnloser S.H., et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001, 103:2072-2077.
27. Doval H.C., Nul D.R., Grancelli H.O., et al. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation 1996, 94:3198-3203.
28. Maggioni A.P., Zuanetti G., Franzosi M.G., et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 1993, 87:312-322.
29. Chen J., Johnson G., Hellkamp A.S., et al. Rapid rate non-sustained ventricular tachycardia found on ICD interrogation: relationship of NSVT to outcomes in the SCD-HeFT Trial. J Am Coll Cardiol 2013, 61:2161-2168.
30. Singh S.N., Fisher S.G., Carson P.E., Fletcher R.D. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators. J Am Coll Cardiol 1998, 32:942-947.
31. Teerlink J.R., Jalaluddin M., Anderson S., et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation 2000, 101:40-46.
32. Buxton A.E., Lee K.L., Hafley G.E., et al. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. J Am Coll Cardiol 2007, 50:1150-1157.
33. Makikallio T.H., Barthel P., Schneider R., et al. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J 2005, 26:762-769.
34. Aliot E.M., Stevenson W.G., Almendral-Garrote J.M., et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace 2009, 11:771-817.
35. Grimm W., Christ M., Bach J., Muller H.H., Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 2003, 108:2883-2891.
36. Tamburro P., Wilber D. Sudden death in idiopathic dilated cardiomyopathy. Am Heart J 1992, 124:1035-1045.
37. Priori S.G., Aliot E., Blomstrom-Lundqvist C., et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2001, 22:1374-1450.
38. Iacoviello M., Forleo C., Guida P., et al. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2007, 50:225-231.
39. Bansch D., Antz M., Boczor S., et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 2002, 105:1453-1458.
40. Zecchin M., Di Lenarda A., Gregori D., et al. Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment?. Pacing Clin Electrophysiol 2008, 31:290-299.
41. Monserrat L., Elliott P.M., Gimeno J.R., Sharma S., Penas-Lado M., McKenna W.J. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 2003, 42:873-879.
42. Fananapazir L., Epstein S.E. Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest. Am J Cardiol 1991, 67:280-287.
43. Adabag A.S., Casey S.A., Kuskowski M.A., Zenovich A.G., Maron B.J. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 2005, 45:697-704.
44. Gimeno J.R., Tome-Esteban M., Lofiego C., et al. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Eur Heart J 2009, 30:2599-2605.
45. Green J.J., Berger J.S., Kramer C.M., Salerno M. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 2012, 5:370-377.
46. Rubinshtein R., Glockner J.F., Ommen S.R., et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 2010, 3:51-58.
47. Adabag A.S., Maron B.J., Appelbaum E., et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008, 51:1369-1374.
48. O'Hanlon R., Grasso A., Roughton M., et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010, 56:867-874.
49. Gersh B.J., Maron B.J., Bonow R.O., et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011, 58:e212-e260.
50. Maron B.J., Spirito P., Ackerman M.J., et al. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol 2013, 61:1527-1535.
51. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2003, 24:1965-1991.
52. Palladini G., Malamani G., Co F., et al. Holter monitoring in AL amyloidosis: prognostic implications. Pacing Clin Electrophysiol 2001, 24:1228-1233.
53. Mehta D., Mori N., Goldbarg S.H., Lubitz S., Wisnivesky J.P., Teirstein A. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol 2011, 4:43-48.
54. Aizer A., Stern E.H., Gomes J.A., Teirstein A.S., Eckart R.E., Mehta D. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 2005, 96:276-282.
55. Sarabanda A.V., Marin-Neto J.A. Predictors of mortality in patients with Chagas' cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 2011, 34:54-62.
56. Rassi A., Rassi A., Rassi S.G. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 2007, 115:1101-1108.
57. Olgun H., Yokokawa M., Baman T., et al. The role of interpolation in PVC-induced cardiomyopathy. Heart Rhythm 2011, 8:1046-1049.
58. Del Carpio Munoz F., Syed F.F., Noheria A., et al. Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden, duration, coupling interval, morphology and site of origin of PVCs. J Cardiovasc Electrophysiol 2011, 22:791-798.
59. Baman T.S., Lange D.C., Ilg K.J., et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm 2010, 7:865-869.
60. Pringle S.D., Dunn F.G., Macfarlane P.W., McKillop J.H., Lorimer A.R., Cobbe S.M. Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy. Am J Cardiol 1992, 69:913-917.
61. McLenachan J.M., Henderson E., Morris K.I., Dargie H.J. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987, 317:787-792.
62. Almendral J., Villacastin J.P., Arenal A., Tercedor L., Merino J.L., Delcan J.L. Evidence favoring the hypothesis that ventricular arrhythmias have prognostic significance in left ventricular hypertrophy secondary to systemic hypertension. Am J Cardiol 1995, 76:60D-63D.
63. Martinez-Rubio A., Schwammenthal Y., Schwammenthal E., et al. Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias or syncope: results of programmed ventricular stimulation and long-term follow-up. Circulation 1997, 96:500-508.
64. Kligfield P., Hochreiter C., Kramer H., et al. Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: contrast to arrhythmias in mitral valve prolapse without mitral regurgitation. Am J Cardiol 1985, 55:1545-1549.
65. Grigioni F., Enriquez-Sarano M., Ling L.H., et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol 1999, 34:2078-2085.
66. Avierinos J.F., Gersh B.J., Melton L.J., et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation 2002, 106:1355-1361.
67. Hayek E., Gring C.N., Griffin B.P. Mitral valve prolapse. Lancet 2005, 365:507-518.
68. Engelfriet P., Boersma E., Oechslin E., et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J 2005, 26:2325-2333.
69. Khairy P., Aboulhosn J., Gurvitz M.Z., et al. Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation 2010, 122:868-875.
70. Gatzoulis M.A., Balaji S., Webber S.A., et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000, 356:975-981.
71. Khairy P., Landzberg M.J., Gatzoulis M.A., et al. Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation 2004, 109:1994-2000.
72. Soteriades E.S., Evans J.C., Larson M.G., et al. Incidence and prognosis of syncope. N Engl J Med 2002, 347:878-885.
73. Edvardsson N., Frykman V., van Mechelen R., et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace 2011, 13:262-269.
74. Krahn A.D., Klein G.J., Yee R., Skanes A.C. Detection of asymptomatic arrhythmias in unexplained syncope. Am Heart J 2004, 148:326-332.
75. Strickberger S.A., Benson D.W., Biaggioni I., et al. AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society. Circulation 2006, 113:316-327.
76. Shimizu W. Arrhythmias originating from the right ventricular outflow tract: how to distinguish "malignant" from "benign"?. Heart Rhythm 2009, 6:1507-1511.
77. Noda T., Shimizu W., Taguchi A., et al. Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract. J Am Coll Cardiol 2005, 46:1288-1294.
78. Viskin S., Rosso R., Rogowski O., Belhassen B. The "short-coupled" variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia?. J Cardiovasc Electrophysiol 2005, 16:912-916.
79. Olshansky B., Poole J.E., Johnson G., et al. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. J Am Coll Cardiol 2008, 51:1277-1282.
80. Phang R.S., Kang D., Tighiouart H., Estes N.A., Link M.S. High risk of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy presenting with syncope. Am J Cardiol 2006, 97:416-420.
81. Haghjoo M., Faghfurian B., Taherpour M., et al. Predictors of syncope in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2009, 32:642-647.
82. Maron B.J. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 2010, 121:445-456.
83. Senges J.C., Becker R., Schreiner K.D., et al. Variability of Holter electrocardiographic findings in patients fulfilling the noninvasive MADIT criteria. Multicenter Automatic Defibrillator Implantation Trial. Pacing Clin Electrophysiol 2002, 25:183-190.
84. Rodriguez F.H., Moodie D.S., Neeland M., Adams G.J., Snyder C.S. Identifying arrhythmias in adults with congenital heart disease by 24-h ambulatory electrocardiography. Pediatr Cardiol 2012, 33:591-595.
85. Parry S.W., Tan M.P. An approach to the evaluation and management of syncope in adults. BMJ 2010, 340:c880.